Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 3 (2006), Issue 10 (October)

1. Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension.
   Obstet Gynecol, 108(4): 826-32. [Abstract] [Full-text]
2. C-reactive protein in hypertension: clinical significance and predictive value.
   Nutr Metab Cardiovasc Dis, 16(7): 500-8. [Abstract] [Full-text]
3. Novel double-congenic strain reveals effects of spontaneously hypertensive rat chromosome 2 on specific lipoprotein subfractions and adiposity.
   Physiol Genomics, 27(1): 95-102. [Abstract] [Full-text]
4. ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.
   Physiol Genomics, 27(1): 12-9. [Abstract] [Full-text]
5. Effect on blood pressure control of switching from valsartan monotherapy to losartan/hydrochlorothiazide in Asian patients with hypertension: results of a multicentre open-label trial.
   Curr Med Res Opin, 22(10): 1955-64. [Abstract] [Full-text]
6. Reduction in extracellular superoxide dismutase activity in African-American patients with hypertension.
   Free Radic Biol Med, 41(9): 1384-91. [Abstract] [Full-text]
7. Renal cortical regulation of COX-1 and functionally related products in early renovascular hypertension (rat).
   Am J Physiol Renal Physiol, 291(5): F987-94. [Abstract] [Full-text]
8. Urea transporter UT-A1 and aquaporin-2 proteins decrease in response to angiotensin II or norepinephrine-induced acute hypertension.
   Am J Physiol Renal Physiol, 291(5): F952-9. [Abstract] [Full-text]
9. Estrogen and salt sensitivity in the female mRen(2).Lewis rat.
   Am J Physiol Regul Integr Comp Physiol, 291(5): R1557-63. [Abstract] [Full-text]
10. 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice.
    Am J Physiol Lung Cell Mol Physiol, 291(5): L905-11. [Abstract] [Full-text]
11. Osteopontin and carotid atherosclerosis in patients with essential hypertension.
    Clin Sci (Lond), 111(5): 319-24. [Abstract] [Full-text]
12. Stenting of hypoplastic aortic segments with mild pressure gradients and arterial hypertension.
    Heart, 92(11): 1661-6. [Abstract] [Full-text]
13. Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage?
    J Neurol Neurosurg Psychiatry, 77(11): 1244-52. [Abstract] [Full-text]
14. Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J).
    BMC Cardiovasc Disord, 6: 39. [Abstract] [Full-text]
15. Association study of G protein-coupled receptor kinase 4 gene variants with essential hypertension in northern Han Chinese.
    Ann Hum Genet, 70: 778-83. [Abstract] [Full-text]
16. G-protein beta3 subunit variant C825T is a risk factor for hypertension in Japanese females--a prospective cohort study over 5 years.
    Ann Hum Genet, 70: 767-77. [Abstract] [Full-text]
17. The genetic dissection of essential hypertension.
    Nat Rev Genet, 7(11): 829-40. [Abstract] [Full-text]
18. A preliminary study of mercury exposure and blood pressure in the Brazilian Amazon.
    Environ Health, 5: 29. [Abstract] [Full-text]
19. Women and hypertension: what did we learn from the Women's Health Initiative?
    Cardiol Rev, 14(6): 267-75. [Abstract] [Full-text]
20. Medical costs of patients with hypertension and/or diabetes: A 10-year follow-up study of National Health Insurance in Shiga, Japan.
    J Hypertens, 24(11): 2305-9. [Abstract] [Full-text]
21. Ethnic disparities in the incidence, presentation and complications of malignant hypertension.
    J Hypertens, 24(11): 2299-304. [Abstract] [Full-text]
22. Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study.
    J Hypertens, 24(11): 2277-84. [Abstract] [Full-text]
23. N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension.
    J Hypertens, 24(11): 2263-70. [Abstract] [Full-text]
24. Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones.
    J Hypertens, 24(11): 2239-46. [Abstract] [Full-text]
25. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension.
    J Hypertens, 24(11): 2231-8. [Abstract] [Full-text]
26. Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats.
    J Hypertens, 24(11): 2215-23. [Abstract] [Full-text]
27. Introversion associated with large differences between screening blood pressure and home blood pressure measurement: The Ohasama study.
    J Hypertens, 24(11): 2183-9. [Abstract] [Full-text]
28. Short-term incidence rate of hypertension in Korea middle-aged adults.
    J Hypertens, 24(11): 2177-82. [Abstract] [Full-text]
29. Prevalence and management of hypertension among Turkish, Moroccan and native Dutch ethnic groups in Amsterdam, the Netherlands: The Amsterdam Health Monitor Survey.
    J Hypertens, 24(11): 2169-76. [Abstract] [Full-text]
30. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.
    J Hypertens, 24(11): 2163-8. [Abstract] [Full-text]
31. How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis.
    J Hypertens, 24(11): 2131-41. [Abstract] [Full-text]
32. Stop Hypertension with the Acupuncture Research Program (SHARP): results of a randomized, controlled clinical trial.
    Hypertension, 48(5): 838-45. [Abstract] [Full-text]
33. Late-onset endothelin-A receptor blockade reduces podocyte injury in homozygous Ren-2 rats despite severe hypertension.
    Hypertension, 48(5): 965-71. [Abstract] [Full-text]
34. Implication of chromosome 18 in hypertension by sibling pair and association analyses: putative involvement of the RKHD2 gene.
    Hypertension, 48(5): 883-91. [Abstract] [Full-text]
35. Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension.
    Hypertension, 48(5): 892-900. [Abstract] [Full-text]
36. Genome-wide scan for premature hypertension supports linkage to chromosome 2 in a large Kyrgyz family.
    Hypertension, 48(5): 908-13. [Abstract] [Full-text]
37. Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study.
    Hypertension, 48(5): 914-20. [Abstract] [Full-text]
38. Importance of salt in determining blood pressure in children: meta-analysis of controlled trials.
    Hypertension, 48(5): 861-9. [Abstract] [Full-text]
39. Changes in antihypertensive prescribing during US outpatient visits for uncomplicated hypertension between 1993 and 2004.
    Hypertension, 48(5): 846-52. [Abstract] [Full-text]
40. Soluble guanylate cyclase stimulation on cardiovascular remodeling in angiotensin II-induced hypertensive rats.
    Hypertension, 48(5): 972-8. [Abstract] [Full-text]
41. Elastolytic cathepsin induction/activation system exists in myocardium and is upregulated in hypertensive heart failure.
    Hypertension, 48(5): 979-87. [Abstract] [Full-text]
42. Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program.
    Hypertension, 48(5): 853-60. [Abstract] [Full-text]
43. Extensive genetic analysis of 10 candidate genes for hypertension in Japanese.
    Hypertension, 48(5): 901-7. [Abstract] [Full-text]
44. Oral renin inhibitors.
    Lancet, 368(9545): 1449-56. [Abstract] [Full-text]
45. African American culture and hypertension prevention.
    West J Nurs Res, 28(7): 831-54; discussion 855-63. [Abstract] [Full-text]
46. Prevalence of overweight and obesity and their association with hypertension and diabetes mellitus in an Indo-Asian population.
    CMAJ, 175(9): 1071-7. [Abstract] [Full-text]
47. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.
    Am J Kidney Dis, 48(5): 739-51. [Abstract] [Full-text]
48. Aortic arch shape deformation after coarctation surgery: effect on blood pressure response.
    J Thorac Cardiovasc Surg, 132(5): 1105-11. [Abstract] [Full-text]
49. Voluntary participation and informed consent to international genetic research.
    Am J Public Health, 96(11): 1989-95. [Abstract] [Full-text]
50. Pregnancy as the prodrome to vascular dysfunction and cardiovascular risk.
    Nat Clin Pract Cardiovasc Med, 3(11): 596-603. [Abstract] [Full-text]
51. Adverse outcomes of renovascular hypertension during pregnancy.
    Nat Clin Pract Nephrol, 2(11): 651-6. [Abstract] [Full-text]
52. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity.
    Nat Clin Pract Nephrol, 2(11): 637-50. [Abstract] [Full-text]
53. Monogenic forms of low-renin hypertension.
    Nat Clin Pract Nephrol, 2(11): 624-30. [Abstract] [Full-text]
54. Inhibitory effects of micronized fenofibrate on carotid atherosclerosis in patients with essential hypertension.
    Clin Chem, 52(11): 2036-42. [Abstract] [Full-text]
55. Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS).
    Am Heart J, 152(5): 867-75. [Abstract] [Full-text]
56. Medium-term variability of blood pressure and potential underdiagnosis of hypertension in patients with previous transient ischemic attack or minor stroke.
    Stroke, 37(11): 2776-83. [Abstract] [Full-text]

© 2004-2010 Hypertension Research Today. All Rights Reserved.